R. Scott Raynovich is the Editor and Publisher of the Rayno Report. He has more than 20 years of experience in analyzing and writing about technology, media, and investment markets. He has been quoted by such outfits as Reuters, Dow Jones, and CNBC.
Have been an active investor for over 4 years trading small and medium cap. biotech stocks. I focus on late stage (Phase III and pending PDUFA) companies with good technicals, fundamentals, and potential for a healthy run-up.